TARDBP and amyotrophic lateral sclerosis: Nearly all cases of amyotrophic lateral sclerosis (ALS) and ~ 45% of frontotemporal dementia (FTD) patients are neuropathologically characterized by neuronal cytoplasmic TDP-43 inclusions accompanied by a nuclear depletion of TDP-43 [1, 42].